The Sensinel CPM system is a remote management wearable device that can detect fluid overload in heart disease patients.

This week on Pipeline Moves, the Clinical Trials Arena team evaluates assets in oncology and metabolic disorders.

There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.

Prime Medicine has received the first-ever IND from the FDA for a prime editing drug which it is investigating in chronic ...

Edgewise Therapeutics has dosed the first subject in a Phase II trial of EDG-7500 for obstructive hypertrophic cardiomyopathy (HCM).

GlycoMimetics has released topline results from its Phase III trial of uproleselan for treating relapsed/refractory acute myeloid leukaemia.

The chance of reviving uproleselan remains slim as Glycomimetics is running short of time and cash to launch another trial.

The study will assess anito-cel’s efficacy and safety against the standard of care in patients with relapsed and/or ...

Innovent is looking to file an NDA to the Chinese authorities for mazdutide in type 2 diabetes in 2024. Image credit: Shutterstock / Halfpoint. Innovent Biologics has said that its type 2 diabetes ...

Can-Fite is actively enrolling patients with MASH in the Phase IIb clinical trial in Europe and Israel. Credit: Emily frost / Shutterstock.com. Can-Fite BioPharma has obtained Investigational New Drug ...

Acumen’s Phase II trial will eventually enroll around 540 people. Image credit: Shutterstock / PopTika. Acumen Pharmaceuticals has dosed the first patient in ALTITUDE-AD, a Phase II trial designed to ...

Pfizer is working with regulators and Data Monitoring Committee to investigate the cause of the patient’s death. Credit: Alexandros Michailidis/ Shutterstock.com. Pfizer has reported the death of a ...